Revenue Update on Selecta Biosciences, Inc. – Common Stock(NASDAQ:SELB)

Selecta Biosciences, Inc. – Common Stock(NASDAQ:SELB) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 9, 2016. Company reported revenue of $2.02M. Analysts estimated a revenue of $1.74M. Earnings per share were $-2.75. Analysts had estimated an EPS of $-0.48.

In a different note, Canaccord Genuity said it Initiates Coverage on Selecta Biosciences, Inc. – Common Stock, according to a research note issued on Jul 18, 2016. The shares have been rated ‘Buy’ by the firm. Stifel Nicolaus said it Initiates Coverage on Selecta Biosciences, Inc. – Common Stock, according to a research note issued on Jul 18, 2016. The shares have been rated ‘Buy’ by the firm. Needham said it Initiates Coverage on Selecta Biosciences, Inc. – Common Stock, according to a research note issued on Jul 18, 2016. The shares have been rated ‘Buy’ by the firm. UBS said it Initiates Coverage on Selecta Biosciences, Inc. – Common Stock, according to a research note issued on Jul 18, 2016. The shares have been rated ‘Buy’ by the firm.

Several Insider Transactions has been reported to the SEC. On Jun 29, 2016, Rusnano (10% owner) purchased 107,143 shares at $14.00 per share price.Also, On Jun 29, 2016, Carl L Gordon (director 10% owner) purchased 550,000 shares at $14.00 per share price.On Jun 29, 2016, Amir Nashat (director 10% owner) purchased 150,000 shares at $14.00 per share price, according to the Form-4 filing with the securities and exchange commission.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *